ALEMBIC LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.68 INR | -0.12% |
|
-4.39% | +8.91% |
| 05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| 05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Real Estate Development & Operations
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 304M | - | - | - | - | - | |
| 25.9B | ||||||
| 26.36B | ||||||
| 25.67B | ||||||
| 24.19B | ||||||
| 20.63B |
